CIK 0002012593
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880724208
- Phone
- +1 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- Open-market buys, last 90 days
- $22,023,904
- in 7 filings
- Open-market sales, last 90 days
- $4,490,340
- in 8 filings, $4.5M under 10b5-1 plans
Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | Third Rock Ventures V, L.P. Director | Grant or award | +238,095 | $21.00 | $5.0M | 6,518,620 |
| 2026-10-30 | Third Rock Ventures V, L.P. Director | Grant or award | +1,190,476 | $21.00 | $25.0M | 2,159,694 |
| 2026-05-26 | Third Rock Ventures V, L.P. 10% owner | Sale 10b5-1 | −18,572 | $40.05 | $744K | 6,280,525 |
| 2026-05-11 | Third Rock Ventures V, L.P. 10% owner | Sale 10b5-1 | −133,618 | $40.24 | $5.4M | 6,299,097 |
| 2026-05-08 | Third Rock Ventures V, L.P. 10% owner | Sale 10b5-1 | −5,018 | $40.31 | $202K | 6,432,715 |
| 2026-05-07 | Third Rock Ventures V, L.P. 10% owner | Sale 10b5-1 | −271,495 | $40.12 | $10.9M | 6,437,733 |
| 2026-04-17 | Third Rock Ventures V, L.P. 10% owner | Sale 10b5-1 | −426,005 | $40.32 | $17.2M | 6,709,228 |
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion | +6,551,449 | 7,135,233 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion | +969,218 | 969,218 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −56,091,177 | 0 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series A Preferred Stock | −8,000,000 | 0 | ||
| 2024-06-10 | Third Rock Ventures V, L.P. 10% owner | Conversion · Series B Preferred Stock | −298,103 | 0 |
Page 1 of 1 · 12 trades